Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Big pharma-backed T-Therapeutics snags $133m to bring TCEs to clinicÂ
T-Therapeutics will now generate proof-of-concept data for its oncology and immunology TCE drugs with “blockbuster” potential.
Read Full Article
Pharma Tech
Podcast: An investor’s guide to preparing your clinical data package
Biotech investor Stephan Christgau speaks about the key considerations when devising a clinical strategy that will attract investor attention.
Read Full Article
Pharma Tech
Evommune signs $1.1bn licence deal with Hinova for EVO570
Evommune has secured exclusive rights outside Greater China to develop EVO570 from Hinova Pharmaceuticals in a deal worth up to $1.1bn.
Read Full Article
PharmaShots
Top 6 AI Phone Agents for Healthcare Practices
Each unanswered call at a medical practice is a patient who’ll simply dial the next clinic on their list. AI phone agents exist to fix that, picking up after hours, collecting intake details, and moving patients toward a booked appointment without hiring more staff. Six platforms stand out in 2026 for both small-to-mid-sized practices and… The post Top 6 AI Phone Agents for Healthcare Practices appeared first on PharmaShots.
Read Full Article
Pharma Tech
PharmatrophiX and Circular partner on neurodegenerative drugs
PharmatrophiX and Circular Genomics have partnered to advance blood-based circular RNA biomarkers in neurodegenerative drug development programmes.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
Pharma Tech
Nov 5, 2026, 3:10 PM
Big pharma-backed T-Therapeutics snags $133m to bring TCEs to clinicÂ
T-Therapeutics will now generate proof-of-concept data for its oncology and immunology TCE drugs with “blockbuster” potential.
PharmaShots
Nov 5, 2026, 11:12 AM
Cloudbreak Reports P-III (CS-301) Topline Data of CBT-001 for Pterygium
Shots: Cloudbreak Pharma has reported topline results from its multi-regional, double-masked, randomized, vehicle-controlled P-III (CS-301) study of CBT-001 ophthalmic emulsion in pts with pterygium (n=659) Both CBT-001 0.1% & 0.2% BID met the 1EPs, showing statistically significant improvement in conjunctival hyperemia at Month 3 vs vehicle (p<0.001; benefit from Week 2 through Month 12) &… The post Cloudbreak Reports P-III (CS-301) Topline Data of CBT-001 for Pterygium appeared first on PharmaShots.
PharmaShots
Nov 5, 2026, 11:10 AM
Evommune Enters Exclusive License Agreement with Hinova for EVO570, an Oral VAV1 Molecular Glue Degrader
Shots: Evommune has entered into an exclusive license agreement with Hinova Pharmaceuticals for worldwide rights (ex-Greater China) to develop, manufacture & commercialize EVO570 (formerly HC118/HP570), an oral VAV1-directed molecular glue degrader Evommune will pay $30M upfront ($20M cash + $10M in pre-funded warrants); Hinova is eligible for up to ~$1.1B in development, regulatory & commercial… The post Evommune Enters Exclusive License Agreement with Hinova for EVO570, an Oral VAV1 Molecular Glue Degrader appeared first on PharmaShots.
PharmaShots
Nov 5, 2026, 11:07 AM
TJ Biopharma Reports P-II (PRIME-1) Data of Plonmarlimab for Macrophage Activation Syndrome
Shots: TJ Biopharma has announced publication of results from PRIME-1, a P-II study of plonmarlimab (anti-GM-CSF mAb) in macrophage activation syndrome (MAS), in the Journal of Hematology & Oncology In 18 glucocorticoid-refractory or relapsed MAS pts, Week-8 ORR was 83.3% (15/18), with median time to response of 2.1wks (earliest Day 5) & an LS-mean 79.3%… The post TJ Biopharma Reports P-II (PRIME-1) Data of Plonmarlimab for Macrophage Activation Syndrome appeared first on PharmaShots.
PharmaShots
Nov 5, 2026, 11:06 AM
Ono’s Sapablursen Receives the EC’s Orphan Medicinal Product Designation for Polycythemia Vera
Shots: Ono Pharmaceutical has reported that the European Commission has granted Orphan Medicinal Product Designation to sapablursen (ONO-0530) for polycythemia vera (PV) Sapablursen previously received US FDA Fast Track (Jan 2024), Orphan Drug (Aug 2024) & Breakthrough Therapy (May 2025) designations, plus Japan Orphan Drug Designation (Sep 2026) A trial-in-progress poster on the global P-III… The post Ono’s Sapablursen Receives the EC’s Orphan Medicinal Product Designation for Polycythemia Vera appeared first on PharmaShots.
PharmaShots
Nov 5, 2026, 11:02 AM
SK Biopharmaceuticals Submits sNDA to the US FDA for Cenobamate in Primary Generalized Tonic-Clonic Seizures
Shots: SK Biopharmaceuticals has submitted an sNDA to the US FDA seeking approval of cenobamate (Xcopri) for primary generalized tonic-clonic (PGTC) seizures & expansion of the existing focal-onset seizure indication to pediatric pts The PGTC filing is supported by a global P-III trial (NCT03678753; n=169 across 122 sites in 12 countries) in pts ≥12yrs., which… The post SK Biopharmaceuticals Submits sNDA to the US FDA for Cenobamate in Primary Generalized Tonic-Clonic Seizures appeared first on PharmaShots.
News
Latest industry coverage
Google News
Nov 5, 2026, 4:08 PM
Alembic Pharma Expands DifGen Partnership to Tap USD 5 Billion US Complex Generics Market - Medical Dialogues
Alembic Pharma Expands DifGen Partnership to Tap USD 5 Billion US Complex Generics Market  Medical Dialogues
Google News
Nov 5, 2026, 4:05 PM
Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027? - The Motley Fool
Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?  The Motley Fool
Google News
Nov 5, 2026, 4:00 PM
Sino Biopharmaceutical Strikes USD 7 Billion Cancer Drug Deal with Germany's Boehringer Ingelheim - Medical Dialogues
Sino Biopharmaceutical Strikes USD 7 Billion Cancer Drug Deal with Germany's Boehringer Ingelheim  Medical Dialogues
Google News
Nov 5, 2026, 3:55 PM
Biodiversity summit saw progress on subsidy reform, but pharma firms push back against fund for Indigenous peoples - Reuters
Biodiversity summit saw progress on subsidy reform, but pharma firms push back against fund for Indigenous peoples  Reuters
Google News
Nov 5, 2026, 3:22 PM
Pfizer plans $650 million manufacturing center in Groton - CT Insider
Pfizer plans $650 million manufacturing center in Groton  CT Insider
Google News
Nov 5, 2026, 3:22 PM
2026 BioTech Breakthrough Honors VectorBuilder With “Overall CGT Solution Provider of the Year” - Business Wire
2026 BioTech Breakthrough Honors VectorBuilder With “Overall CGT Solution Provider of the Year”  Business Wire
Google News
Nov 5, 2026, 3:17 PM
Biotech company that expanded to S.D. from Germany grows with downtown Sioux Falls office, future lab - SiouxFalls.Business
Biotech company that expanded to S.D. from Germany grows with downtown Sioux Falls office, future lab  SiouxFalls.Business
Google News
Nov 5, 2026, 3:04 PM
Vaishali Pharma NSE:VAISHALI Board Meeting Outcome November 2026 - Kalkine India
Vaishali Pharma NSE:VAISHALI Board Meeting Outcome November 2026Â Â Kalkine India
Google News
Nov 5, 2026, 3:04 PM
Biocodex Invests €15 Million in a New Industrial Platform for Live Biotherapeutic Products - Business Wire
Biocodex Invests €15 Million in a New Industrial Platform for Live Biotherapeutic Products  Business Wire
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer